Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Learning About Parkinson’s Diseaseand OFF Time
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Committed to Making a Difference
What is Little Big Things?
We believe smallinnovations have the potential to make a big impact and improve the lives of people living with Parkinson's.
A Sunovion-sponsored innovation platform for the Parkinson’s Community.
We believe in the power of one person, one idea, one event at a time.
LITTLE BIG THINGS is a trademark of Sunovion Pharmaceuticals Inc.
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Placeholder: RML to play RapidHack Sizzle Video NPC-APL031-18
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
What is a RapidHack?
A 2-day event bringing together patients, advocates, and medical specialists
The goal: come up with ideas for innovative solutions to the complex problems faced by PD patients and caregivers
The RapidHack Challenge: design a product or service that addresses daily challenges and may help PD patients regain a sense of independence
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Join Us
Follow us on Facebookhttps://www.facebook.com/LittleBigThings
Register to learn more!https://www.littlebigthings.com
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Today You Will Learn About
6
Personal Testimonial: Living With Parkinson’s Disease 1
Parkinson’s Disease, its Symptoms, and Treatment Options2
OFF Time, the Different Types, and How it Could Affect Your Life3
Talking to Your Doctor About Parkinson’s Disease and OFF Time4
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Sunovion is Committed to Offering Solutions to Help Manage the Unique Experiences of Parkinson’s Disease
7
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
8
POLLING QUESTION
What is your current level of understanding of the 4 main types of OFF time?
High degree of understanding
Average degree of understanding
Low degree to no understanding
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Personal Testimonial ‒ Living with Parkinson’s Disease
9 PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18.
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Parkinson’s Disease Expert
10
Speaker is a paid consultant of Sunovion Pharmaceuticals Inc.PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18.
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Parkinson’s Disease, its Symptoms, and Treatment Options
11 PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18.
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Did You Know:
12
1. Fahn S, et al. Chapter 4: Parkinsonism: Clinical features and differential diagnosis. In: Fahn S, Jankovic J, Hallett M, Eds. Principles and Practice of Movement Disorders. 2nd Ed. Edinburgh, UK: W.B. Saunders; 2011:66-92; 2. Parkinson’s Foundation Statistics. http://parkinson.org/Understanding-Parkinsons/Causes-and-Statistics/Statistics. Accessed August 31, 2018 3. AANS. Parkinson’s Disease. http://www.aans.org/Patients/Neurosurgical-Conditions-and-Treatments/Parkinsons-Disease. Accessed March 15, 2018; 4. DeMaagd G, et al. P.T. 2015;40:504-532.
About 1 millionAmericans live with Parkinson’s disease2
~60,000 new cases in the United States each year3
Age (years)20 40 60 80
Average onset is 60 years of age4
Parkinson’s diseaseis a progressive disorder of the nervous system1
~1,000,0002
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Motor Symptoms in People with Parkinson’s Disease
13
• Freezing
• Shuffling or slow walking
• Reduced facial expression
• Reduced blink rate
• Small handwriting
• Less hand control
• Soft voice and unclear speech
• Swallowing problems
• Difficulty turning in bed
Tremor
Difficulties with postural reflexes
Slow movement
Other Motor Symptoms
Rigidity
Primary Motor Symptoms
Fahn S, et al. Principles and Practice of Movement Disorders. 2nd Ed. Edinburgh, UK: W.B. Saunders; 2011:66-92.
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Non-motor Symptoms in People with Parkinson’s Disease
14
• Depression/sadness
• Fatigue
• Anxiety/panic attacks
• Slowness of thinking
• Memory problems
• Pain
• Inability to stay still
• Burning sensations
• Restless legs
Sensory
• Lightheadedness
• Constipation
• Poor bladder control
• Drenching sweats
• Shortness of breath
Autonomic Mood/Thinking
Martínez-Fernández R, et al. Mov Disord. 2016;31:1080-1094.
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Gastrointestinal (GI) Symptoms in People with Parkinson’s Disease
15*Assessed in patients with early stage Parkinson’s disease. Poirier AA, et al. Parkinsons Dis. 2016;2016:6762528. doi: 10.1155/2016/6762528.
GI symptoms may be present in 60% to 80% of patients with Parkinson s disease*
GI Symptoms May Include: • Constipation• Difficulty swallowing• Excess saliva• Impaired emptying of stomach
contents into intestines
ExperienceGI Symptoms
Do Not Experience GI Symptoms
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
16
POLLING QUESTION
Which of these symptoms of Parkinson’s disease do you experience?
Motor symptoms
Non-motor symptoms
Motor and non-motor symptoms
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Dopamine and Parkinson’s Disease
17
1. Best JA, et al. Theor Biol Med Model. 2009;6:1-20; 2. Politis M, et al. Neuroimage Clin. 2017;16:455-460; 3. Fahn S, Jankovic J, Hallett M. Chapter 4: Parkinsonism: Clinical features and differential diagnosis. In: Fahn S, Jankovic J, Hallett M, Eds. Principles and Practice of Movement Disorders. 2nd Ed. Edinburgh, UK: W.B. Saunders; 2011:66-92.
• Dopamine carries signals between brain cells (neurons)1
• These signals may impact movement and other, non-motor functions1
• In Parkinson’s disease, neurons that make dopamine die off, resulting in less dopamine2
– The reasons for this are still unclear3
Dopaminergic Neuron1
Dopamine Receptors
Dopamine
Levodopa
Dopaminergic Neuron1
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
What Medications Are Used to Treat Parkinson’s Disease?
18
Imitate dopamine• Dopamine agonists
Enhance dopamine• Levodopa-containing medications
Slow down the breakdown of levodopa• MAO-B inhibitors• COMT inhibitors
MAO-B, monoamine oxidase B; COMT, catechol-O-methyltransferase. Factor SA. Neurotherapeutics. 2008;5(2):164-180.
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Potential Difficulties with Orally Swallowed Levodopa*
These gut-related factors may slow or prevent medicationfrom reaching the brain.1
*Levodopa is the gold standard for treating patients with Parkinson’s disease.41. Poewe W, et al. Clin Interv Aging. 2010;5:229-238; 2. Müller T, et al. Clin Neuropharmacol. 2006;29:61-67; 3. Tan AH, et al. Parkinsonism Relat Disord. 2014;20:535-540. 4. Nishijima H, et al. Front Neurosci. 2016;10(575):1-9.19
Swallowing problems are common in patients with PD1
High-protein meals may interfere with how well levodopa is absorbed1
Reduced gastric emptying results in lower medication levels in the blood and the brain2
The growth of bacteria in the gut may interfere with how well medicationsare absorbed3
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
OFF Time, the Different Types, andHow it Could Affect Your Life
20
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18.
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Parkinson’s Disease Symptoms: “ON” Versus “OFF”
21 1. Olanow WC, et al. Neurology. 2009;72(Suppl 4):S1-S136; 2. Chou KL, et al. Parkinsonism Relat Disord. 2018;51:9-16.
ON
OFF
When you feel your Parkinson’s disease symptoms are improved by your medication, this is considered to be an ON time1,2
When symptoms reappear or worsen, you are experiencing an OFF time1,2
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
As Parkinson’s Disease Progresses, OFF Times May Become More Common1,2
22
.
Early Parkinson’s Disease
642LevodopaTime (h)
ON Time
ON With Dyskinesias (Involuntary Muscle Movements)
OFF Time
Clin
ical
Effe
ct
This graph shows a hypothetical patient with early PD. The line indicates the patient’s response to a dose of levodopa.
1. Olanow C. et al. Harrison's Principles of Internal Medicine, 19e. New York, NY: McGraw-Hill; 2014.2. Obeso JA, et al. Neurology. 2000;55(11 Suppl 4):S13-S20.Olanow C. et al. Harrison's Principles of Internal Medicine, 19/E. New York, NY: McGraw-Hill; 2014; Copyright © McGraw-Hill Education. Adapted with permission.
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
As Parkinson’s Disease Progresses, OFF Times May Become More Common1,2
23
.
642LevodopaTime (h)
ON Time
OFF Time
Moderate Parkinson’s DiseaseC
linic
al E
ffect
ON With Dyskinesias (Involuntary Muscle Movements)
This graph shows a hypothetical patient with moderate PD. The line indicates the patient’s response to a dose of levodopa.
1. Olanow C. et al. Harrison's Principles of Internal Medicine, 19e. New York, NY: McGraw-Hill; 2014.2. Obeso JA, et al. Neurology. 2000;55(11 Suppl 4):S13-S20.Olanow C. et al. Harrison's Principles of Internal Medicine, 19/E. New York, NY: McGraw-Hill; 2014; Copyright © McGraw-Hill Education. Adapted with permission.
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
As Parkinson’s Disease Progresses, OFF Times May Become More Common1,2
24
.
642LevodopaTime (h)
ON Time
ON With Dyskinesias (Involuntary Muscle Movements)
OFF Time
Advanced Parkinson’s DiseaseC
linic
al E
ffect
This graph shows a hypothetical patient with advanced PD. The line indicates the patient’s response to a dose of levodopa.
1. Olanow C. et al. Harrison's Principles of Internal Medicine, 19e. New York, NY: McGraw-Hill; 2014.2. Obeso JA, et al. Neurology. 2000;55(11 Suppl 4):S13-S20.Olanow C. et al. Harrison's Principles of Internal Medicine, 19/E. New York, NY: McGraw-Hill; 2014; Copyright © McGraw-Hill Education. Adapted with permission.
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Main Types of OFF Time
25
Morning OFF
Wearing OFF
Delayed ON
Unpredictable OFF
Chou KL, et al. Parkinsonism Relat Disord. 2018;51:9-16
?
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
26
POLLING QUESTION
Do you experience OFF time in the morning?
Yes
No
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Main Types of OFF Time
27
Morning OFF
Wearing OFF
Delayed ON
Unpredictable OFF
Chou KL, et al. Parkinsonism Relat Disord. 2018;51:9-16
?
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
28
POLLING QUESTION
Do you experience wearing OFF?
Yes
No
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Main Types of OFF Time
29 Chou KL, et al. Parkinsonism Relat Disord. 2018;51:9-16
Morning OFF
Wearing OFF
Delayed ON
Unpredictable OFF?
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
30
POLLING QUESTION
Do you experience unpredictable OFF time?
Yes
No
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Main Types of OFF Time
31 Chou KL, et al. Parkinsonism Relat Disord. 2018;51:9-16
Morning OFF
Wearing OFF
Delayed ON
Unpredictable OFF?
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
32
POLLING QUESTION
Do you experience dose failure or partial ON?
Yes
No
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Patients with Parkinson’s Disease May Have Several OFF Times Each Day
33
Based on a 2014 survey conducted by the Michael J. Fox Foundation of approximately 3000 patients with Parkinson’s disease. Survey data did not specify the patients’ levels of PD severity. Patients’ treatment regimens were unknown. Michael J. Fox Foundation for Parkinson’s Research. Executive summary: survey of Parkinson’s patients and their off time experience.
92% of patients report ≥1 OFF time 40% of patients report
≥3 OFF times
64% of patients had 2+ hours of OFF time each day20% of patients report
≥4 OFF times
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
34
POLLING QUESTION
On average, how many OFF times do you experience per day?
0
1 to 2
3 to 4
5 or more
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
35
POLLING QUESTION
On average, how much of a delay does morning OFF time causein your day?
No delay
1 hour or less
1–2 hours
More than 2 hours
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Exercise May Improve Many Parkinson’s Disease Symptoms
361. Snider, J, et al. Parkinsonism Relat Disord. 2015;21:1227-1231; 2. Prodoehl J, et al. Neurorehab Neural Repair. 2015;29:112-122; 3. Park A, et al. Parkinsonism Relat Disord. 2014;20:106-111.
Increasing sedentary behavior has been linked to more severe Parkinson’s disease motor symptoms1
Exercise may improve balance, mobility, depression, and overall qualityof life2,3
Exercise may have the potential to slow Parkinson’s disease progression, but more research in humans is needed3
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Talking to Your Doctor AboutParkinson’s Disease and OFF Time
37 PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18.
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
The Ball Is in Your Court: Be Empowered to Speak to Your Doctor and Ask Questions
38
Tell your doctor about all your motor and non-motor symptomsand when they are happening
What should I do if my medication beginsto wear OFF before my next dose?
Can I take my medication whenOFF symptoms begin to occur even if it
is not time for the next dose?
How long should it take my medicationto start working?
What if I take a dose and nothing happens?
Speak to your doctor at each office visitabout your Parkinson’s disease and
if you are experiencing OFF time
Should my medication be workingthe same throughout the day?
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
39
POLLING QUESTION
Does your doctor ask about OFF time routinely?
Yes
No
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Key Takeaways
40
Parkinson’s disease is a progressive disorder of the nervous system that affects about 1 million Americans
Patients with Parkinson’s disease may experience OFF time, associated with both motor and non-motor symptoms
OFF time may become more frequent as the disease progresses
Because there are different types of OFF time, it is important to talk to your doctor about your symptoms and when you are experiencing OFF time
Parkinson’s Foundation Statistics. http://parkinson.org/Understanding-Parkinsons/Causes-and-Statistics/Statistics. Accessed August 31, 2018
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
41
POLLING QUESTION
After attending this educational session, how has your levelof OFF time understanding changed?
Significantly increased
Somewhat increased
Little or not increased
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
What Questions Do You Have?
42 PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18.
PROPERTY OF SUNOVION PHARMACEUTICALS INC. PROPRIETARY AND NONTRANSFERRABLE. NOT FOR FURTHER DISSEMINATION. © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18
Thank You!
Remember to visit www.LittleBigThings.com for more information!
SUNOVION and are registered trademarks of Sumitomo Dainippon Pharma Co., Ltd.Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Sumitomo Dainippon Pharma Co., Ltd.LITTLE BIG THINGS is a trademark of Sunovion Pharmaceuticals Inc. Sunovion Pharmaceuticals Inc., 84 Waterford Drive, Marlborough, MA 01752 © 2018 Sunovion Pharmaceuticals Inc. All rights reserved. 10/18 NPC-APL319-18